Prof Dr. Kyu Sang Lee | Pathology | Best Researcher Award

Dr. Kyu Sang Lee is an Associate Professor in the Department of Pathology at Seoul National University Bundang Hospital, South Korea. He holds an MD from Eulji University and a PhD in Translational Medicine from Seoul National University College of Medicine. With extensive experience in pathology, Dr. Lee has contributed significantly to cancer research, publishing numerous high-impact articles in esteemed journals. He is recognized for his innovative work, including the development of an AI-powered PD-L1 combined positive score analyzer, which has implications for cancer diagnostics. Dr. Lee has received multiple awards for his research presentations, showcasing his peers’ acknowledgment of his contributions. Additionally, he is an active member of several professional pathology societies, reflecting his commitment to advancing the field. As a dedicated educator, he plays a vital role in training future pathologists, making him a prominent figure in the pathology community.

Dr. Kyu Sang Lee has an impressive educational background that underscores his expertise in the field of pathology. He earned his Doctor of Medicine (M.D.) degree from Eulji University, College of Medicine, in Daejeon, Korea, in 2008. Following this, he pursued further specialization in neuroscience, obtaining a Master of Science (M.S.) degree from Seoul National University College of Medicine in 2012. Dr. Lee continued to advance his academic credentials by completing his Doctor of Philosophy (Ph.D.) in Translational Medicine at the same institution in 2018. His educational journey has equipped him with a comprehensive understanding of both clinical and research aspects of pathology, providing a solid foundation for his subsequent roles in academia and clinical practice. This rigorous training has enabled Dr. Lee to make significant contributions to the field, particularly in cancer research and diagnostics, positioning him as a leader in his discipline.

Dr. Kyu Sang Lee is an accomplished academic and medical professional currently serving as an Associate Professor in the Department of Pathology at Seoul National University Bundang Hospital. His career began with a residency in Pathology at Seoul National University Hospital, where he developed a strong foundation in diagnostic pathology. He advanced through various roles, including Instructor and Fellow, before becoming an Assistant Professor in 2017. Dr. Lee further expanded his expertise as a Visiting Professor at the University of California, Los Angeles, from 2021 to 2023. His research has focused on translational medicine and cancer pathology, with significant contributions to artificial intelligence applications in diagnostics. Dr. Lee has published extensively, including notable works on urothelial carcinoma and glioblastoma, and has received multiple awards for his research presentations at international conferences. His professional experience reflects a commitment to advancing pathology through research, education, and clinical practice.

Dr. Kyu Sang Lee’s research interests lie primarily in the field of pathology, with a strong focus on cancer diagnostics and therapeutics. He is particularly engaged in exploring the molecular and cellular mechanisms underlying various cancers, including glioblastoma and colorectal cancer. His work involves utilizing advanced techniques such as next-generation sequencing and artificial intelligence to improve the accuracy and efficiency of cancer diagnosis, particularly in identifying biomarkers for targeted therapies. Dr. Lee is also interested in the implications of immune checkpoint proteins, such as PD-L1, in tumor biology and their potential as therapeutic targets. Additionally, he studies the clinicopathologic characteristics of different tumor types, aiming to enhance personalized medicine approaches. His commitment to translational research ensures that his findings have practical applications in clinical settings, ultimately contributing to improved patient outcomes and advancing the field of oncology.